Diamond Biofund follows the United Nations Sustainable Development Goals “SDG 3: Promote Health and Well-being,” “SDG 5: Gender Equality,” and “SDG 8: Promote Economic Growth and Employment” to create a friendly, motivating work environment that encourages employees to enhance their self-worth. We believe that achieving sustainable business practices and continuously building and developing talent is key to success. The company enhances human capital from multiple angles, offering diverse learning channels and comprehensive training programs to equip employees with the professional knowledge and communication and management skills needed to face new challenges, while also ensuring mental and physical well-being.
2025 Training Goals
Diamond Biofund continues to invest in talent development, aiming for mutual growth with employees. In 2025, through general education, the company fostered a learning atmosphere within the organization, aiming to enhance professional and ESG general competencies. Below are our employee career development plans and learning outcomes:
2025 Education and Training Results
| Item | Number of participants | Total hours | Average hours | Cost(NTD) |
| Professional competency training (Including external training) | 105 | 267 | 12.14 | 63,788 |
| General training | 163 | 234 | 10.64 | 42,000 |
| New employee training | 10 | 30 | 3 | 0 |
| Total | 278 | 531 | 25.77 | 105,788 |
In August 2021, Diamond Biofund introduced the “New Employee Mentoring System.” The company assigns managers or senior colleagues as mentors to assist new employees in quickly mastering company operations, departmental tasks, and job responsibilities.
Diamond Biofund’s human resource management follows three core pillars: recruitment, talent development, and retention. In terms of retention, the company bases its compensation system on industry characteristics, market trends, and future development. Compensation and rewards are provided based on the achievement of company goals and departmental and employee performance evaluations, with stock options offered as an incentive to encourage employees to contribute to the company’s operational performance and long-term value. The company’s compensation policy is based on job roles and responsibilities, with no differences in employee compensation based on gender, race, religion, political stance, marital status, or union membership. The company is committed to sharing its operational results and profits with employees, ensuring that compensation complies with the Labor Standards Act. The compensation policy is based on roles and responsibilities, with bonuses distributed according to annual performance evaluations, without gender-based differences.









醣基生醫股份有限公司
2017年9月27日登錄興櫃市場交易 (6586:TT)
公司所在地
台北,台灣
公司設立日期
2013
登錄公開市場
2017
公司官網
https://www.chopharma.com/cn/index.html